Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,294.9
0.0 (0.00%)

 

  • STI Straits Times Index
    3,294.9
    0.0 (0.00%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,527.1
    -0.7 (-0.05%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,965.5
    13.2 (0.05%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,522.6
    -32.5 (-0.91%)
    Index delayed 15 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 805.0M
  • Value: 1,097.8M
  • Rise: 135
  • Fall: 158
  • Unch: 474

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.086+0.003
DISA0.009+0.001
ThaiBev0.660+0.005
The Place Hldg0.074+0.016
Geo Energy Res0.355+0.025
Sembcorp Marine0.083-
Arion Ent0.011+0.001
Singtel2.480+0.010
Oceanus0.029+0.001
Genting Sing0.775-0.005

World Indices

World Indices
Name Last Change
Nasdaq 13,768.9 -385.1
HSI 24,965.5 +13.2
HSCEI 8,787.3 +25.7
Jakarta 6,726.4 +99.5
Nikkei 225 27,522.3 -250.7
SSE Comp 3,522.6 -32.5
Shanghai A 3,691.5 -34.1
Shanghai B 286.2 -0.8
KOSPI 2,834.3 -28.4

Nikkei 225 updated at end-of-day. Other Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

TalkMed TALKMED GROUP LIMITED
Quotes 10 Minutes Delayed. Updated at 21 Jan 2022 16:49
Last (SGD): 0.400 Change: +0.010 High: 0.400 Remarks: -
Change (%): +2.56 Low: 0.400
Open 0.400 Yesterday's Close 0.390
Buy Price 0.390 Sell Price 0.400
Buy Volume ('000) 26.7 Sell Volume ('000) 49.4
Cumulative Volume ('000) 0.6 Cumulative Value 240

Company Background

TalkMed Group Limited is a Singapore-based investment holding company. The Company's principal activities are the provision of medical oncology services and stem cell transplant services. The Company's segments include Oncology services and Stem cells services. Its doctors provide tertiary healthcare services in the fields of medical oncology, stem cell transplant and palliative care to the oncology patients in the private sector in Singapore through Parkway Cancer Centre (PCC). Its clinical functions include attending to patients, examination and administering medical treatment to patients and performing minor outpatient surgical procedures, prescribing medicines and investigations, such as laboratory tests or diagnostic procedures. These clinical functions also include the review of investigation results and follow-up care with the patient. It provides medical oncology services and palliative care services with approximately 13 doctors at over eight clinics.

Click to show Stock Prices chart

Key Statistics

EPS (SGD) a 0.01725 Trailing EPS (SGD) b 0.01733 NAV (SGD) c 0.0642
PE a 23.188 Trailing PE d 23.075 Price / NAV c 6.2305
Dividend Yield (%) e 3.370 Cash In Hand (SGD) f 0.0613 Issued & Paid-up Shares g 1,320,109,000
Piotroski F Score 3 Market Cap (M) 528.044 Free Float (%) 16.7
Return on Equity (ROE) (%) h 26.987 Revenue Growth (%) TTM i -15.202
Net Earnings Growth (%) j -25.668 Net Debt/Equity k Net Cash
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Health and Social Services - Medical/Nursing Services
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted based on Profit Attributable To Shareholders.
  2. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  3. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  4. Based on latest Full Year results announcement, adjusted for the current number of shares.
  5. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  6. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  7. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 05 Aug 2021. Please click here for more information.
  8. Calculated based on Net Earnings / (Shareholders' Equity - Other Share Capital)
  9. Calculated based on (Current Year Revenue - Last Year Revenue) / Last Year Revenue
  10. Calculated based on (Current Year Earnings - Last Year Earnings) / Last Year Earnings
  11. Calculated based on (Long Term Debt + Short Term Debt - Cash and Short Term Investments)/(Shareholders' Equity - Other Share Capital)

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days ---
10 Days -+0.010
+2.56 %
20 Days -+0.010
+2.56 %
Medium Term Return 3 Months --0.010
-2.44 %
6 Months 0.007-0.010
-0.73 %
1 Year 0.015-0.045
-6.74 %
Long Term Return 2 Years 0.034-0.105
-14.06 %
3 Years 0.054-0.150
-17.45 %
5 Years 0.106-0.218
-18.12 %
Annualised Return Annualised --
-3.92 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference TalkMed SGX 528.044 23.188 23.075 6.2305 3.370
Industry Medical & Biotechnology SGX 1,031.157 19.055 15.677 1.4406 1.904
Medical/Nursing Services SGX 98.235 21.955 27.195 2.3192 3.451
Index FTSE ST Catalist Index SGX 60.528 26.260 20.709 1.3736 2.088
Local Peer Cordlife SGX 94.461 14.431 14.746 0.7124 2.426
Local Peer Asian Healthcare SGX 92.973 20.774 20.771 1.6701 4.116
Local Peer HC Surgical SGX 77.424 9.678 10.131 8.9041 7.692
Local Peer Clearbridge SGX 61.104 99.000 - 0.9950 -
Local Peer Alliance HC SGX 34.302 22.388 22.390 1.7799 1.394
Local Peer Sing Paincare SGX 30.536 13.878 13.880 1.2967 4.412
Local Peer Medinex SGX 30.178 8.640 7.272 1.7139 7.304
Local Peer AsiaMedic SGX 17.912 - - 2.0000 -
Local Peer RHT HealthTrust SGX 15.417 - - 0.9645 -
Global Peer JD HEALTH INTERNATIONAL INC HKEx 226,179.096 - - 4.7581 -
Global Peer FRESENIUS MEDICAL CARE AG & CO KGAA SPON ADR-EACH REP 0.5 NPV NYSE 19,168.354 14.441 17.486 1.3524 1.752
Global Peer SONIC HEALTHCARE ASX 18,637.015 14.172 14.172 2.9189 2.334
Global Peer DAVITA INC NYSE 11,146.841 14.231 11.324 9.6977 -
Global Peer CHEMED CORP NYSE 7,244.117 22.676 23.545 9.2907 0.290
Global Peer GUARDANT HEALTH INC NASDAQ 7,126.086 - - 10.0450 -
Global Peer AGILON HEALTH INC NYSE 6,424.450 - - 5.6969 -
Global Peer NATERA INC NASDAQ 5,934.878 - - 7.8191 -
Global Peer ACADIA HEALTHCARE NASDAQ 4,770.184 24.438 21.855 1.9595 -
Global Peer AMEDISYS INC NASDAQ 4,337.097 23.622 19.698 4.7910 -
Other Global Peers OAK STREET HEALTH INC (NYSE), ENSIGN GROUP INC (NASDAQ), OPTION CARE HEALTH INC (NASDAQ), LHC GROUP INC (NASDAQ), LIFESTANCE HEALTH GROUP INC (NASDAQ), CANO HEALTH INC (NYSE), JINXIN FERTILITY GROUP LTD (HKEx), NEOGENOMICS INC (NASDAQ), INVITAE CORP (NYSE), PRIVIA HEALTH GROUP INC (NASDAQ), MEDNAX INC (NYSE), HEALIUS LTD (ASX), 1LIFE HEALTHCARE INC (NASDAQ), FULGENT GENETICS INC (NASDAQ), NEW HORIZON HEALTH LTD (HKEx), EC HEALTHCARE (HKEx), RADNET INC (NASDAQ), APRIA INC (NASDAQ), RAM (SET), Metro Healthcare Indonesia Tbk. (IDX), ADDUS HOMECARE CORP (NASDAQ), SVH (SET), TIVITY HEALTH INC (NASDAQ), US PHYSICAL THERAPY (NYSE), KPJ (Bursa), AVEANNA HEALTHCARE HOLDINGS INC (NASDAQ), C-MER EYE CARE HLDGS LTD (HKEx), CASTLE BIOSCIENCES INC (NASDAQ), BURNING ROCK BIOTECH LTD SPON ADS EACH REP 1 ORD SHS CL A (NASDAQ), YONGHE MEDICAL GROUP CO LTD (HKEx), AUSTRALIAN CLINICA (ASX), SMILEDIRECTCLUB INC (NASDAQ), ATI PHYSICAL THERAPY INC (NYSE), HANGER INC (NYSE), OCEANIA HEALTHCARE LTD (ASX), KINDSTAR GLOBALGENE TECHNOLOGY INC (HKEx), GLOBAL CORD BLOOD CORPORATION (NYSE), CHAOJU EYE CARE HOLDINGS LTD (HKEx), PENNANT GROUP INC (NASDAQ), THE ONCOLOGY INSTITUTE INC (NASDAQ), VIRTUS HEALTH LIMITED (ASX), FINCH THERAPEUTICS GROUP INC (NASDAQ), GENETRON HOLDINGS LIMITED SPON ADS EACH REP 5 ORD SHS (NASDAQ), EUROEYES INTL EYE CLINIC LTD (HKEx), TOWN HEALTH INTL MEDICAL GP LTD (HKEx), GLOBAL X FDS ARTIFICIAL INTELLIGENCE AND TECH ETF (NASDAQ), UPHEALTH INCORPORATED (NYSE), TALKSPACE INC (NASDAQ), SERA PROGNOSTICS INC (NASDAQ), HEALTHIA LTD (ASX), PROGENITY INC (NASDAQ), APTINYX INC (NASDAQ), CLOVER CORP (ASX), SONIDA SENIOR LIVING INC (NYSE), OPTINOSE INC (NASDAQ), SANARA MEDTECH INC (NASDAQ), SILK LASER AUSTRALIA LTD (ASX), CARDIFF ONCOLOGY INC (NASDAQ), AKUMIN INC (NASDAQ), EXAGEN INC (NASDAQ), GUANGDONG KANGHUA HEALTHCARE CO LTD (HKEx), SPLASH BEVERAGE GROUP INC (NYSE American), FIELD TRIP HEALTH LTD (NASDAQ), BIODESIX INC (NASDAQ), AESTHETIC MEDICAL INT HLDGS GRP LTD SPON ADS EACH REP 3 ORD SHS (NASDAQ), PRO-DEX INC (NASDAQ), KATO (HK) HOLDINGS LTD (HKEx), UMP HEALTHCARE HOLDINGS LIMITED (HKEx), MHCARE (Bursa), OPTIMAX (Bursa), INOVIQ LTD (ASX), GREENBROOK TMS INC (NASDAQ), RAILY AESTHETIC MEDICINE INTL HLDGS (HKEx), ONTRAK INC (NASDAQ), ORTHOCELL LIMITED (ASX), Diagnos Laboratorium Utama Tbk. (IDX), CONCORD MEDICAL SERVICES HLDGS LTD ADS EACH 1 REPR 3 ORD SHS (USD0.0001) (NYSE), HUMAN HEALTH HOLDINGS LTD (HKEx), BIOCEPT INC (NASDAQ), KDH (SET), IMAC HOLDINGS INC (NASDAQ), NOVO INTEGRATED SCIENCES INC (NASDAQ), D (SET), ONCOSEC MEDICAL INCORPORATED (NASDAQ), REPUBLIC HEALTHCARE LTD (HKEx), CHINA HEALTH GROUP LTD (HKEx), GBS INC (NASDAQ), BCAL DIAGNOSTICS LIMITED (ASX), SMILE (Bursa), CHINA WAH YAN HEALTHCARE LIMITED (HKEx), WAH YAN-OLD (HKEx), RMH HLDGS LTD (HKEx), TOTAL BRAIN LTD (ASX), GUARDION HEALTH SCIENCES INC (NASDAQ), AMERICAN SHARED HOSPITAL SERVICES (NYSE American), MEDINET GROUP LTD (HKEx), MOHO RESOURCES NL (ASX), SMILES INCLUSIVE LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

More Information Available

More information is available to our subscribers, including:

  • Consensus Estimates
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.